|
Major fatty acids (chemical names) and their chemical structures | | Molecular formulae | Contents (%/g, dried seeds) [47–51] | Pharmacological effects |
|
Erucic acid (cis-13-docosenoic acid) | | C22H42O2 | 10.20–13.27 | N/A |
|
Oleic acid (cis-9-octadecenoic acid)
| | C18H34O2 | 7.62–1.22 | Anticancer effect via targeting at telomerase inhibitor [58] |
|
Linoleic acid -Linolenic acid (9,12,15-octadecatrienoic acid)
| -Linolenic acid (6,9,12-octadecatrienoic acid)
| C18H32O2 | 3.30–5.17 | Effective on atherosclerosis induced by cholesterol-rich diet [59], Control blood-lipid levels of patients with hyperlipidemia [60] |
|
Eicosenoic acid*
| | C20H38O2 | 3.08–3.99 | N/A |
|
Palmitic acid (hexadecanoic acid)
| | C16H32O2 | 1.86–2.24 | N/A |
|
Stearic acid (octadecanoic acid)
| | C18H36O2 | 0.65–0.97 | Lowering low-density lipoprotein cholesterol level [61] |
|
Nervonic acid (cis-15-tetracosanoic acid)
| | C24H46O2 | 0.45–0.74 | Serving as a dietary therapy in demyelinating diseases [62], Preventive effects on obesity-related metabolic disorders [63] |
|
Myristic acid (tetradecanoic acid)
| | C14H28O2 | Trace | Prevention of testosterone-induced prostatic hyperplasia in rats [64] |
|
Arachidic acid (eicosanoic acid)
| | C20H40O2 | Trace | N/A |
|
Eicosadienoic acid (11,14-eicosadienoic acid)
| | C20H36O2 | Trace | N/A |
|
Behenic acid (docosanoic acid)
| | C22H44O2 | Trace | N/A |
|
Lignoceric acid (tetracosanoic acid)
| | C24H48O2 | Trace | Activation of NADPH oxidase in human dermal fibroblasts [65] |
|
Palmitoleic acid (cis-9-hexadecenoic acid)
| | C16H30O2 | Trace | Reduction of insulin resistance and hepatic lipid accumulation by chronic administration [66] |
|